|
|
|
|
Vol. 14, Issue 9, 3507-3518, September 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cytoplasmic Domain Regulates the Laminin-binding Specificity of the
7X1 Integrin


||
* Department of Stomatology, University of California at San Francisco, San Francisco, CA 94143-0512;
Department of Anatomy, University of California at San Francisco, San Francisco, CA 94143-0512
Submitted December 15, 2002;
Revised May 16, 2003;
Accepted May 18, 2003
Monitoring Editor: Jean Schwarzbauer
During muscle development, the laminin-specific
7 integrin is alternatively spliced in the putative ligand-binding domain to yield either the
7X1 or the
7X2 variant. The relative level of
7X1 and
7X2 is developmentally regulated. Similarly, the partner
1 integrin cytoplasmic domain is converted from the
1A to the
1D splice variant. To determine whether
1D modulates the activity of the
7 receptor, cells were transfected with
7X1 and
1D cDNA.
7X1 coupled with
1A failed to adhere to laminin-1, whereas cotransfectants expressing
7X1 and
1D showed strong adhesion. Interestingly,
7X1 complexed with
1A and
1D displayed the same level of poor adhesion to laminin-2/4 or strong adhesion to laminin-10/11. These findings indicate that
7 function is regulated not only by X1/X2 in its extracellular domain but also by
1 cytoplasmic splice variants. It is likely that expression of
1D alters
7X1 binding to laminin isoforms by a process related to ligand affinity modulation. Functional regulation of
7
1 by developmentally regulated splicing events may be important during myogenic differentiation and repair because the integrin mediates adhesion, motility, and cell survival.
Abbreviations used: DMSO, dimethyl sulfoxide; FACS, fluorescence-activated cell sorting; FITC, fluorescein isothiocyanate; mAb, monoclonal antibody; MTJ, myotendinous junction; NMJ, neuromuscular junction; pAb, polyclonal antibody; PCR, polymerase chain reaction.
Present addresses: Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA 19104
Present addresses: Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, GR-54006, Thessaloniki, Greece.
|| Corresponding author. E-mail address: rkramer{at}itsa.ucsf.edu.